Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sharps Technology, Inc. (STSS : NSDQ)

• Company Description    Sharps Technology Inc. is a medical device company offering patented, best-in-class, single use smart safety syringe products. Sharps Technology Inc. is based in NEW YORK. Number of Employees: 55

• Price / Volume Information    Yesterday's Closing Price: $1.81 Daily Weekly Monthly 20 Day Moving Average: 253,597 shares Shares Outstanding: 42.32 (millions) Market Capitalization: $76.60 (millions) Beta: 2.03 52 Week High: $18.23 52 Week Low: $1.42 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.09% -5.92% 12 Week 0.56% -7.04% Year To Date -10.84% -14.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 105 MAXESS ROAD STE. 124 - MELVILLE,NY 11747 USA ph: 631-574-4436 fax: - stss@redchip.com https://sharpstechnology.com

• General Corporate Information    Officers Paul K. Danner - Principal Executive Officer; Interim Principal Fin Arthur Levine - Chief Financial Officer Soren Bo Christiansen - Director Timothy J. Ruemler - Director Jason L. Monroe - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 82003F309 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 42.32 Most Recent Split Date: 4.00 (0.00:1) Beta: 2.03 Market Capitalization: $76.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.43 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -103.08% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -157.91 12/31/25 - -145.95 09/30/25 - -84.26 ROA 03/31/26 - -154.40 12/31/25 - -140.73 09/30/25 - -79.52 Current Ratio 03/31/26 - 8.28 12/31/25 - 4.02 09/30/25 - 3.74 Quick Ratio 03/31/26 - 8.08 12/31/25 - 3.88 09/30/25 - 3.67 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - -205,990.44 12/31/25 - -132,517.16 09/30/25 - -118,573.81 Book Value 03/31/26 - 4.22 12/31/25 - 9.12 09/30/25 - 15.35 Inventory Turnover 03/31/26 - 0.94 12/31/25 - 0.49 09/30/25 - 2.02 Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©